Genomic analysis of adult thrombotic microangiopathies in less than 3 days: From rapid to fast genomics to treatment.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
28 Aug 2024
28 Aug 2024
Historique:
accepted:
07
08
2024
received:
15
04
2024
revised:
07
08
2024
medline:
29
8
2024
pubmed:
29
8
2024
entrez:
28
8
2024
Statut:
aheadofprint
Résumé
Using nanopore sequencing, we showed feasibility and impact of rapid genomic screening for managing thrombotic microangiopathies (TMAs) in 18 prospective cases, achieving diagnoses in less than three days. We compared results to standard exome sequencing, cost-efficiency and complement blockade initiation.
Identifiants
pubmed: 39197070
pii: 517605
doi: 10.1182/blood.2024024976
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 American Society of Hematology.